Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples

Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples

<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causing agent for COVID-19, has led to over 7 million deaths since it was first detected in Wuhan, China in December 2019. Antibodies induced by both vaccination and infection are crucial for the immune protection ag...

Fuld beskrivelse

Bibliografiske detaljer
Hovedforfatter:	Liu, C
Andre forfattere:	Screaton, GR
Format:	Thesis
Sprog:	English
Udgivet:	2024
Fag:	Immunology

Lignende værker

SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract
af: Alba Escalera, et al.
Udgivet: (2024-03-01)

Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
af: Xiao-Lin Jiang, et al.
Udgivet: (2024-07-01)

Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
af: Cyril Planchais, et al.
Udgivet: (2024-07-01)

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
af: Jeewandara, C, et al.
Udgivet: (2021)

Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
af: Jay, C
Udgivet: (2023)

Nonhuman primate antigenic cartography of SARS-CoV-2
af: Annika Rössler, et al.
Udgivet: (2025-01-01)

Studies on immunoreceptor activation and SARS-CoV-2 RBD/ACE2 interactions
af: Barton, MI
Udgivet: (2022)

Anti-SARS-CoV-2 antibodies in a nasal spray efficiently block viral transmission between ferrets
af: Kiira Gildemann, et al.
Udgivet: (2024-07-01)

SARS-CoV-2 produces a microRNA CoV2-miR-O8 in patients with COVID-19 infection
af: Elise J. Tucker, et al.
Udgivet: (2024-01-01)

Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies
af: Youngchang Kim, et al.
Udgivet: (2024-02-01)

Development of human monoclonal antibodies against SARS-CoV-2
af: Wong, Joel Xu En
Udgivet: (2021)

SARS-CoV-2 infection elucidates features of pregnancy-specific immunity
af: Dong Sun Oh, et al.
Udgivet: (2024-11-01)

Multivariate analyses and machine learning link sex and age with antibody responses to SARS-CoV-2 and vaccination
af: Miroslava Cuperlovic-Culf, et al.
Udgivet: (2024-08-01)

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
af: Tetsuya Inoue, et al.
Udgivet: (2024-04-01)

Increasing Sporadic Covid-19 Cases:Should We Heed Airborne Transmission Of SARS-CoV-2?
af: Ahmad Mahfuz, Gazali
Udgivet: (2021)

An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
af: Banghui Liu, et al.
Udgivet: (2024-06-01)

Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control
af: Liu, G
Udgivet: (2023)

Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2
af: Martina Severa, et al.
Udgivet: (2024-05-01)

SARS-CoV-2 vaccine development and challenges
af: Duan Fugang, et al.
Udgivet: (2021-03-01)

Elucidating factors of heterogeneous immune response to SARS-CoV-2 and human immunodeficiency virus
af: Lim, N
Udgivet: (2024)

Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1
af: Zhou Tong, et al.
Udgivet: (2024-06-01)

SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity
af: Elizabeth J. Martinez, et al.
Udgivet: (2024-10-01)

Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections
af: Sung-Gwon Lee, et al.
Udgivet: (2024-03-01)

Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
af: Cara W. Chao, et al.
Udgivet: (2024-12-01)

SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
af: Sarah E. Cummings, et al.
Udgivet: (2024-01-01)

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
af: Carter, Brandon, et al.
Udgivet: (2023)

tANCHOR-cell-based assay for monitoring of SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domains
af: Daniel Ivanusic, et al.
Udgivet: (2024-03-01)

Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1
af: Alexander Muik, et al.
Udgivet: (2024-08-01)

Convergence of SARS-CoV-2 spike antibody levels to a population immune setpointResearch in context
af: Eric J. Nilles, et al.
Udgivet: (2024-10-01)

Characterising the T cell responses to SARS-CoV-2 including variants of concern induced by natural infection and vaccines
af: Adele, S
Udgivet: (2024)

Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters
af: Rajesh Rajaiah, et al.
Udgivet: (2024-08-01)

Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
af: Lu Zhang, et al.
Udgivet: (2024-06-01)

Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection
af: Mohamed I.M. Ahmed, et al.
Udgivet: (2024-06-01)

Immune imprinting of SARS-CoV-2 responses: changing first immune impressions
af: J. Torresi, et al.
Udgivet: (2024-04-01)

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine
af: Masayuki Aboshi, et al.
Udgivet: (2024-02-01)

A systems biology approach to define SARS-CoV-2 correlates of protection in non-human primates
af: Brady, C
Udgivet: (2024)

The alarmin IL-33 exacerbates pulmonary inflammation and immune dysfunction in SARS-CoV-2 infection
af: Hui Wang, et al.
Udgivet: (2024-06-01)

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
af: Willett, BJ, et al.
Udgivet: (2022)

SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
af: Hirsch, C, et al.
Udgivet: (2021)

SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
af: Kreuzberger, N, et al.
Udgivet: (2021)